Cardiology - Prova Education

1-16 of 30

MinuteCE®
The Underestimated Consequences of Uncontrolled Gout: Renal and Cardiovascular Implications
Richard Johnson, MD; Abdul Abdellatif, MD, FASN
- Richard Johnson, MD
- Abdul Abdellatif, MD, FASN
- John K. Botson, MD, RPh
- Brittany Weber, MD, PhD
Should We Look for Gout in the Cardiology Clinic?
Should We Look for Gout in the Cardiology Clinic?
MinuteCE®
Should We Look for Gout in the Cardiology Clinic?
Richard Johnson, MD; Brittany Weber, MD, PhD
- Richard Johnson, MD
- Brittany Weber, MD, PhD
What Are the Emerging Therapies for Managing Gout?
What Are the Emerging Therapies for Managing Gout?
MinuteCE®
What Are the Emerging Therapies for Managing Gout?
Richard Johnson, MD; John K. Botson, MD, RPh
- Richard Johnson, MD
- John K. Botson, MD, RPh
What’s New About Gout? Rheumatology Perspective
What’s New About Gout? Rheumatology Perspective
MinuteCE®
What’s New About Gout? Rheumatology Perspective
Richard Johnson, MD; John K. Botson, MD, RPh
- Richard Johnson, MD
- John K. Botson, MD, RPh
What’s New About Gout? Nephrology Perspective
What’s New About Gout? Nephrology Perspective
MinuteCE®
What’s New About Gout? Nephrology Perspective
Abdul Abdellatif, MD, FASN; Richard Johnson, MD
- Abdul Abdellatif, MD, FASN
- Richard Johnson, MD
Can You Manage Patients With Uncontrolled Gout More Effectively?
Can You Manage Patients With Uncontrolled Gout More Effectively?
MinuteCE®
Can You Manage Patients With Uncontrolled Gout More Effectively?
Abdul Abdellatif, MD, FASN; John K. Botson, MD, RPh
- Abdul Abdellatif, MD, FASN
- John K. Botson, MD, RPh
Treat or Refer: Who Is Responsible for Managing Gout?
Treat or Refer: Who Is Responsible for Managing Gout?
MinuteCE®
Treat or Refer: Who Is Responsible for Managing Gout?
John K. Botson, MD, RPh; Abdul Abdellatif, MD, FASN
- John K. Botson, MD, RPh
- Abdul Abdellatif, MD, FASN
Center of the Target: Which Patients Are Most Likely to Develop Gout?
Center of the Target: Which Patients Are Most Likely to Develop Gout?
MinuteCE®
Center of the Target: Which Patients Are Most Likely to Develop Gout?
Richard Johnson, MD; Abdul Abdellatif, MD, FASN
- Richard Johnson, MD
- Abdul Abdellatif, MD, FASN
Is Managing Gout in the Nephrology Clinic a Challenge?
Is Managing Gout in the Nephrology Clinic a Challenge?
MinuteCE®
Is Managing Gout in the Nephrology Clinic a Challenge?
Richard Johnson, MD; Abdul Abdellatif, MD, FASN
- Richard Johnson, MD
- Abdul Abdellatif, MD, FASN
Is Gout Hiding in the Nephrology Clinic?
Is Gout Hiding in the Nephrology Clinic?
MinuteCE®
Is Gout Hiding in the Nephrology Clinic?
Abdul Abdellatif, MD, FASN; Richard Johnson, MD
- Abdul Abdellatif, MD, FASN
- Richard Johnson, MD
Gout Beyond the Joints: What’s the Hidden Danger?
Gout Beyond the Joints: What’s the Hidden Danger?
MinuteCE®
Gout Beyond the Joints: What’s the Hidden Danger?
Richard Johnson, MD
- Richard Johnson, MD
Use of Statins for the Prevention of Cardiovascular Disease
Use of Statins for the Prevention of Cardiovascular Disease
The JAMA Report™
Use of Statins for the Prevention of Cardiovascular Disease
New Medication for High Cholesterol Not Cost-Effective
New Medication for High Cholesterol Not Cost-Effective
The JAMA Report™
New Medication for High Cholesterol Not Cost-Effective
Device Reduces Risk of Brain Injury After Heart Valve Replacement
Device Reduces Risk of Brain Injury After Heart Valve Replacement
The JAMA Report™
Device Reduces Risk of Brain Injury After Heart Valve Replacement
Reducing Complications of High Blood Pressure in Older Adults
Reducing Complications of High Blood Pressure in Older Adults
The JAMA Report™
Reducing Complications of High Blood Pressure in Older Adults
Pathogenesis and Management of Non-Alcoholic Fatty Liver Disease
Pathogenesis and Management of Non-Alcoholic Fatty Liver Disease
Lipid Luminations
Pathogenesis and Management of Non-Alcoholic Fatty Liver Disease
Alan S. Brown, MD, FACC, FAHA, FNLA
- Alan S. Brown, MD, FACC, FAHA, FNLA

Prev
1
2
Next

1/2